THE NUMBER OF BIOPSY CORES TAKEN IS A MAJOR PREDICTOR OF UNFAVORABLE PROSTATE CANCER AT FINAL PATHOLOGY IN PATIENTS CANDIDATE FOR ACTIVE SURVEILLANCE: CLINICAL IMPLICATIONS